Pfizer, NCPA Agree Therapeutic Substitution Should Not Be Part Of Medicare
Executive Summary
Pfizer and the National Community Pharmacists Association believe therapeutic substitution is not among the pharmacist care services that should be reimbursed under a Medicare prescription drug benefit.
You may also be interested in...
PCMA Preparing To Challenge Anti-PBM Lobbying At State Level
The Pharmaceutical Care Management Association is beefing up its state-level lobbying to counteract anti-PBM activity by retail pharmacy groups
PCMA Preparing To Challenge Anti-PBM Lobbying At State Level
The Pharmaceutical Care Management Association is beefing up its state-level lobbying to counteract anti-PBM activity by retail pharmacy groups
Pharmacy Groups Exploring Medicare Rx Fallback Options
The retail pharmacy trade associations hope to reach an agreement on a fallback Medicare drug benefit proposal with a group of pharmaceutical manufacturers over the next month